Abstract:Background: MiR-92a has been discovered to be involved in the malignant behavior of various types of cancers. However, the particular clinical and prognostic roles of miR-92a in tumors still need to be identified more precisely. The current meta-analysis assessed the prognostic value of miR-92a in various carcinomas. Methods: Systematic literature searches of PubMed, PMC, Web of Science (WOS), Embase in English and Wanfang, SinoMed and the China National Knowledge Infrastructure (CNKI) in Chinese up to Jan 15th 2019 were conducted for eligible studies. Twenty studies involving a total of 2573 patients were included in the analysis. Pooled hazard ratios (HR) for overall survival (OS) and disease-free survival (DFS), progression-free survival (PFS) and recurrence-free survival (RFS) were assessed using fixed-effects and random-effects models. Meta-regression and subgroup analyses were carried out to explore the source of heterogeneity. Odds ratio (OR) and 95%CIs were applied to evaluate the relationship between miR-92a expression levels and clinicopathological characteristics. Results: A significant association between miR-92a levels and OS (HR=2.18) was identified. The random pooling model also revealed significance of consistency (HR=2.14), indicating that the stability of the results. Subgroup analyses were performed and the corresponding significance was recognized in Chinese cancer patients (HR=2.35), studies of specimen derived from tissues (HR=2.43), non-hematological cancer (HR=2.35), osteosarcoma (HR=2.54), non-small cell lung cancer (HR=2.33), hepatocellular carcinoma (HR=2.40) and so on. There were significant relations observed of the expression level of miR-92a to tumor size (≥5 vs <5 cm) (OR=2.13), lymph node metastasis (present vs. absent) (OR=1.87), distant metastasis (present vs. absent) (OR=2.99) and so on. Conclusions: the over expression of miR-92a is associated with unfavorable prognosis of Chinese cancer patients. In addition, patients of elevated miR-92a expression level are likely to develop the cancers of more malignant behaviors.

miR-92a family and their target genes in tumorigenesis and metastasis.

Molecular Mechanisms and Clinical Applications of Mir-22 in Regulating Malignant Progression in Human Cancer (Review)

Expression, regulation and mechanism of action of the miR-17-92 cluster in tumor cells (Review)

Investigation of MiR-92a As a Prognostic Indicator in Cancer Patients: a Meta-Analysis

Function of miR-19a and miR-92a determined by seed-targeting inhibition in multiple myeloma cells and their signal pathway analysis

MicroRNA-92a promotes growth, metastasis, and chemoresistance in non-small cell lung cancer cells by targeting PTEN

Microrna-92b Acts As An Oncogene By Targetingpten/Aktinnsclc

MicroRNA-183 in Cancer Progression

The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis

MiR-92a modulates proliferation, apoptosis, migration and invasion of osteosarcoma cell lines by targeting Dickkopf-related protein 3.

miR-92a is upregulated in cervical cancer and promotes cell proliferation and invasion by targeting FBXW7.

MiR-92a Promotes Cell Metastasis of Colorectal Cancer Through PTEN-Mediated PI3K/AKT Pathway

Prognostic role of miR-17-92 family in human cancers: evaluation of multiple prognostic outcomes.

<scp>MicroRNA</scp>‐92b acts as an oncogene by targeting <scp>PTEN</scp>/<scp>AKT</scp> in <scp>NSCLC</scp>

Role of Mir-17-92 Gene Cluster in Tumor Development and Progression

MicroRNA-92a Regulates the Development of Cutaneous Malignant Melanoma by Mediating FOXP1

The miR-200 Family of microRNAs: Fine Tuners of Epithelial-Mesenchymal Transition and Circulating Cancer Biomarkers

MicroRNA-92a Functions as an Oncogene in Colorectal Cancer by Targeting PTEN

Dysregulation and Functional Roles of Mir-183-96-182 Cluster in Cancer Cell Proliferation, Invasion and Metastasis

Feud or Friend? the Role of the Mir-17-92 Cluster in Tumorigenesis

MicroRNAs in cancer metastasis and angiogenesis